acebutolol has been researched along with Cerebrovascular Disorders in 4 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acebutolol seemed to cause stroke earlier with the more rapid BP elevation." | 1.26 | Effects of beta-adrenergic blocking drugs in hypertensive rats. ( Shiono, K; Sokabe, H; Sukamoto, T; Watanabe, TX, 1980) |
| "Acebutolol was compared with oxprenolol in the treatment of 17 CVD patients with hypertension of long standing, 14 of whom had cardiac abnormalities and 16 retired abnormalities." | 1.26 | Comparative study of acebutolol and oxprenolol in the management of hypertensive cerebrovascular diseases (CVD) patients. ( Almatsier, M; Ranakusuma, TA; Soemargo, S; Tobing, SM, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sukamoto, T | 1 |
| Shiono, K | 1 |
| Watanabe, TX | 1 |
| Sokabe, H | 1 |
| Ranakusuma, TA | 1 |
| Tobing, SM | 1 |
| Almatsier, M | 1 |
| Soemargo, S | 1 |
| Mason, DT | 1 |
| Chan, MC | 1 |
| Lee, G | 1 |
| Bes, A | 1 |
| Dupui, P | 1 |
| Guell, A | 1 |
| Géraud, G | 1 |
1 review available for acebutolol and Cerebrovascular Disorders
| Article | Year |
|---|---|
Antihypertensive therapy and the concept of total cardiovascular protection.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; | 1987 |
1 trial available for acebutolol and Cerebrovascular Disorders
| Article | Year |
|---|---|
Antihypertensive therapy and the concept of total cardiovascular protection.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; | 1987 |
3 other studies available for acebutolol and Cerebrovascular Disorders
| Article | Year |
|---|---|
Effects of beta-adrenergic blocking drugs in hypertensive rats.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Cerebrovascular Disorders; Hypertension; Kidney; M | 1980 |
Comparative study of acebutolol and oxprenolol in the management of hypertensive cerebrovascular diseases (CVD) patients.
Topics: Acebutolol; Adult; Aged; Antihypertensive Agents; Central Nervous System; Cerebrovascular Disorders; | 1981 |
[Acebutolol and cerebral blood flow of the moderately hypertensive aged subject].
Topics: Acebutolol; Aged; Cerebrovascular Disorders; Female; Frontal Lobe; Homeostasis; Humans; Hypertension | 1986 |